![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.447, 2004-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Which fetal monitoring strategy best bet in Sweden?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 570, 2009-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Which dengue control strategy best bet in Brazil?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 628, 2011-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Which antenatal screening strategy best bet in Scotland?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 485, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Glatiramer acetate best bet in RRMS?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 531, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Brachytherapy best bet for oesophageal cancer?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 571, 2009-01 ,pp. :